ClinicalTrials.gg
CompletedNCT02961972Updated Jul 31, 2017

Effects of Oral Supplementation With Creatine on Systemic Microvascular Endothelial Function in Vegetarian Individuals

An interventional study of monohydrate and micronized creatine and placebo in Endothelial Dysfunction and Hyperhomocysteinemia, sponsored by National Institute of Cardiology, Laranjeiras, Brazil. Completed at 1 site in Brazil. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-07-31.

Sponsored by National Institute of Cardiology, Laranjeiras, Brazil · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The present study aims at investigating the effects of the oral supplementation with creatine on the systemic microvascular reactivity and plasma levels of homocysteine in vegetarian individuals of the vegan type.

Read the detailed description

A vegetarian is an individual who lives on a diet of grains, pulses, legumes, nuts, seeds, vegetables, fruits, fungi, algae, yeast and/or some other non-animal-based foods, with or without, dairy products, honey and/or eggs. A vegetarian does not eat foods that consist of, or have been produced with the aid of products consisting of or created from, any part of the body of a living or dead animal. This includes meat, poultry, fish, shellfish, insects, by-products of slaughter** or any food made with processing aids created from these.

There are different types of vegetarian: i) Lacto-ovo-vegetarians eat both dairy products and eggs; this is the most common type of vegetarian diet; ii) Lacto-vegetarians eat dairy products but avoid eggs; iii) Ovo-vegetarians eat eggs but not dairy products; iv) Vegans do not eat dairy products, eggs, or any other products which are derived from animals.

Vegetarian individuals are considered to have lower cardiovascular risk for the development of cardiovascular diseases and lower cardiovascular mortality, when compared to omnivore individuals.

Nevertheless, some vegetarian diets may result in the deficiency of micronutrients and induce deficiency in some compounds such as vitamins, amino-acids, iron, zinc, calcium, omega-3 fatty acids and so on.

Moreover, vegetarian individuals can present deficiency in amino-acids such as carnosine and creatine, present essentially in the skeletal muscle of animals. In this context, deficiency in creatine has been considered as a risk factor for hyperhomocysteinemia and the consequent dysfunction of the vascular endothelium.

Hyperhomocysteinemia also is known to be an independent risk factor for cardiovascular diseases similar to hypertension, smoke and dyslipidemia.

In the present study, we investigate the effects of creatine supplementation in the systemic microvascular endothelial function and density in vegan-vegetarians presenting with normo- or hyperhomocysteinemia using laser-based skin flowmetry and video-capillaroscopy. We also investigate the effects of creatine supplementation on lipid and glycemic profile and plasma homocysteine levels.

Microvascular reactivity is evaluated using a laser speckle contrast imaging system in combination with the iontophoresis of acetylcholine (ACh), for the noninvasive and continuous measurement of cutaneous microvascular perfusion changes.

Microvascular density in the skin is evaluated using intravital video-microscopy.

02

Conditions studied

  • Endothelial Dysfunction
  • Hyperhomocysteinemia

Browse trials for

Keywords

  • vegetarianism
  • Hyperhomocysteinemia
  • vegan vegetarian
03

In context

Hyperhomocysteinemia

34 studies on the registry are indexed under Hyperhomocysteinemia; 4 are open to participants now.

This study's enrollment of 49 is below the median of 84 across 21 interventional studies indexed under Hyperhomocysteinemia.

Browse Hyperhomocysteinemia studies →

Lead sponsor

National Institute of Cardiology, Laranjeiras, Brazil is the lead sponsor of 21 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • healthy vegetarians of the vegan type

Exclusion criteria

Exclusion Criteria:

  • previous treatment with dietary supplements
  • high intensity physical activity
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
49 participants (actual)

Study arms

  • Placebo comparator
    control group

    Oral ingestion of placebo pills (maltodextrin) during three weeks

    Other: placebo

  • Experimental
    creatine supplementation

    Oral supplementation with 5 g of monohydrate and micronized creatine during three weeks

    Dietary Supplement: monohydrate and micronized creatine

Interventions

  • Dietary supplementmonohydrate and micronized creatine

    oral supplementation with creatine

  • Otherplacebo

    oral supplementation with maltodextrin (control group)

06

What researchers measure

Primary outcomes

  1. Reactivity of the systemic microcirculation

    Assessment of the endothelial-dependent microvascular reactivity in the skin using laser speckle contrast imaging

    Time frame: three-week treatment

Secondary outcomes

  1. cutaneous microvascular density

    Assessment of skin microvascular density using video-capillaroscopy

    Time frame: three-week treatment

  2. Homocysteine levels in the plasma

    Time frame: three-week treatment

07

Study locations

1 site
  • National Institute of Cardiology, Ministry of Health, Brazil
    Rio de Janeiro, 22240-006, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2015, a primary completion of Jun 2017 and a completion of Jun 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2016
First posted
Nov 11, 2016
Start
Jan 2015
Primary completionActual
Jun 2017
CompletionActual
Jun 2017
Last update
Jul 31, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02961972
Lead sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Responsible party
Eduardo Tibirica (MD, PhD, National Institute of Cardiology, Laranjeiras, Brazil) — Principal investigator
First posted
Nov 11, 2016
Start date
Jan 2015
Primary completion
Jun 2017
Completion
Jun 2017
Last update
Jul 31, 2017

Study contacts

Eduardo Tibirica, MD, PhD
principal investigator · National Institute of Cardiology

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion